12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Naloxone regulatory update

The European Commission granted Orphan Drug designation for Elorac's naloxone lotion to treat cutaneous T cell lymphoma...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >